Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
Clinical trial NCT04023396 · COMPLETED
Trial details
- NCT number
- NCT04023396
- Sponsor
- Abivax S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2023-02-23
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.